VaramirStart free · no cardSign in
SRRK as of Oct 31 · 19:42 ET
SRRKNasdaqBiological Products, (No Diagnostic Substances)

Scholar Rock Holding Corp · Brief

Next report

13 days

Nov 13 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
1 of 8≥ implied
avg implied
±10.9%
avg realized
±6.6%
Feb 27 '25±12.3%▼−2.86%×0.23
May 14 '25±10.6%▼−2.74%×0.26
Aug 6 '25±8.7%▼−6.40%×0.74
Q3 FY25±12.2%▲+24.41%×2.00
Jan 12 '26±9.8%▲+3.27%×0.34
Q1 FY26±13.3%▲+1.91%×0.14
May 7 '26±8.4%▼−1.40%×0.17
Q2 FY26±11.7%▲+9.96%×0.85
quarterimplied−25%0+25%realized×
Q2 FY26±11.7%▲+9.96%×0.85
May '26±8.4%▼−1.40%×0.17
Q1 FY26±13.3%▲+1.91%×0.14
Jan '26±9.8%▲+3.27%×0.34
Q3 FY25±12.2%▲+24.41%×2.00
Aug '25±8.7%▼−6.40%×0.74
2 older reports
May '25±10.6%▼−2.74%×0.26
Feb '25±12.3%▼−2.86%×0.23
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 13 report · est.

Bull2 of 4

5disclosed supplier and customer ties in SEC filingsSEC filings
5tracked funds holding SRRKN-PORT · Aug 31 '26

Bear2 of 4

7 of 8recent reports where the move came in under the options-implied rangeEarnings history
1.16%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

SRRK report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 30impliedImplied move: ±9.5% into Nov 13 earnings (Oct 30 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.